BioCentury
ARTICLE | Company News

Axxam, Hit Discovery Constance, Lead Discovery Center, Centre for Drug Design and Discovery (CD3) supply/service, high throughput screening news

January 20, 2014 8:00 AM UTC

CRO Axxam, biotech Lead Discovery and the technology transfer platform and investment fund CD3 debuted their JV, Hit Discovery Constance GmbH, to provide drug discovery research services, including as...